Mads Hald Andersen

Mads Hald Andersen

Clinical Professor

Member of:


    1. 2018
    2. Published

      Immunoregulatory antigens-novel targets for cancer immunotherapy

      Pedersen, A. W., Kopp, K. L., Andersen, Mads Hald & Zocca, M., Apr 2018, In: Chinese Clinical Oncology. 7, 2, p. 1-8 19.

      Research output: Contribution to journalJournal articleResearchpeer-review

    3. Published

      Sorted peripheral blood cells identify CALR mutations in B- and T-lymphocytes

      Kjaer, L., Holmström, M. O., Cordua, S., Andersen, Mads Hald, Svane, Inge Marie, Thomassen, M., Kruse, T. A., Pallisgaard, N., Skov, V. & Hasselbalch, Hans Carl, Apr 2018, In: Leukemia and Lymphoma. 59, 4, p. 973-977 5 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    4. Published

      The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy

      Holmstrom, M. O., Martinenaite, E., Ahmad, S. M., Met, Özcan, Friese, C., Kjaer, L., Riley, C. H., Straten, P. T., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 1 Feb 2018, In: Leukemia. 32, 2, p. 429-437

      Research output: Contribution to journalJournal articleResearchpeer-review

    5. Published

      Durable clinical responses and long-term follow-up of stage III-IV non-small-cell lung cancer (NSCLC) patients treated with IDO peptide vaccine in a phase i study-a brief research report

      Kjeldsen, J. W., Iversen, T. Z., Engell-Noerregaard, L., Mellemgaard, A., Andersen, Mads Hald & Svane, Inge Marie, 2018, In: Frontiers in Immunology. 9, SEP, 6 p., 2145.

      Research output: Contribution to journalJournal articleResearchpeer-review

    6. Published

      Frequent adaptive immune responses against arginase-1

      Martinenaite, E., Mortensen, R. E. J., Hansen, M., Orebo Holmström, M., Munir Ahmad, S., Grønne Dahlager Jørgensen, N., Met, Özcan, dqp123, dqp123, Svane, Inge Marie & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 3, 9 p., e1404215.

      Research output: Contribution to journalJournal articleResearchpeer-review

    7. Published

      Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin

      Woetmann, Anders , Alhede, M., Dabelsteen, Sally, Bjarnsholt, Thomas, Rybtke, Morten Levin, Nastasi, C., Krejsgaard, T., Andersen, Mads Hald, Bonefeld, Charlotte Menne, Geisler, Carsten, Givskov, Michael & Ødum, Niels, 2018, In: OncoTarget. 9, 28, p. 19481-19489 9 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    8. Published

      Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies

      Klausen, U., Holmberg, S., Holmstrom, M. O., Jorgensen, N. G. D., Grauslund, J. H., Svane, Inge Marie & Andersen, Mads Hald, 2018, In: Frontiers in Immunology. 9, 8 p., 2264.

      Research output: Contribution to journalReviewResearchpeer-review

    9. Published

      Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutation

      Jørgensen, M. A., Holmström, M. O., Martinenaite, E., Riley, C. H., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 9, 8 p., e1468957.

      Research output: Contribution to journalJournal articleResearchpeer-review

    10. Published

      Spontaneous T-cell responses against the immune check point programmed-death-ligand 1 (PD-L1) in patients with chronic myeloproliferative neoplasms correlate with disease stage and clinical response

      Holmström, M. O., Riley, C. H., Skov, V., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 6, e1433521.

      Research output: Contribution to journalJournal articleResearchpeer-review

    11. Published

      The balance players of the adaptive immune system

      Andersen, Mads Hald, 2018, In: Cancer Research. 78, 6, p. 1379-1382

      Research output: Contribution to journalReviewResearchpeer-review

    Previous 1 2 Next

    ID: 13571778